“Dupilumab Improves Symptoms of Anxiety and Depression in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of Three Phase 3 Trials (LIBERTY AD SOLO 1 and 2 and ADOL)”, J of Skin, vol. 4, no. 5, p. s48, Sep. 2020, doi: 10.25251/skin.4.supp.47.